RXR Acquisition registered with the SEC to offer 25 million units at $10 each.
The new SPAC in the S-1 filing said it will target a business combination that operates at the intersection of real estate and technology, or proptech.
CEO Scott Rechler has served as CEO and chairman of RXR since 2007. He is also a member of the Real Estate Board of New York, a board member of The Feinstein Institute for Medical Research, a board member of Northwell Healthcare (the largest healthcare provider in New York State), and a member of the NYU Real Estate Institute Advisory Committee.
The SPAC intends to list on the Nasdaq under RXRAU. Read more.
